Brief: Index Pharmaceuticals Q4 Oper Loss Widens To SEK 22.7 Mln

Flerie AB

23/02/2022 07:25

Feb 23 (Reuters) - 
    * INDEX PHARMACEUTICALS HOLDING AB (PUBL) YEAR-END REPORT
2021
    * Q4 NET SALES AMOUNTED TO SEK 0.0 (0.0) MILLION
    * Q4 OPERATING LOSS AMOUNTED TO SEK -22.7 (-10.1) MILLION
    * THE BOARD WILL NOT PROPOSE A DIVIDEND FOR 2021. THE BOARD 
HAS
NO INTENTION TO PROPOSE A DIVIDEND UNTIL INDEX CAN  FORECAST
LONG TERM PROFIT AND SUSTAINABLE POSITIVE CASH FLO

Source text for Eikon:  ID:nWkr8Msncb 
Further company coverage:  INDEX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))